Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study | Zendy

Ludmilа Milоvаnоvа | Zendy; Marina Taranova | Zendy; Alexey V. Volkov | Zendy; Svetlana Milоvаnova | Zendy; Vladimir Beketov | Zendy

Open Access

Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study

Author(s) -

Ludmilа Milоvаnоvа,

Marina Taranova,

Alexey V. Volkov,

Svetlana Milоvаnova,

Vladimir Beketov

Publication year - 2022

Publication title -

terapevticheskii arkhiv

Language(s) - English

Resource type - Journals

eISSN - 2309-5342

pISSN - 0040-3660

DOI - 10.26442/00403660.2022.06.201567

Subject(s) - medicine , randomized controlled trial , kidney disease , prospective cohort study , disease , clinical trial , soy protein , pathology

It has been established that the use of a low-protein diet (LPD) in combination with ketoanalogues (KA) of essential amino acids can contribute to cardio- and nephroprotection in chronic kidney disease (CKD). Moreover, it has been shown that replacing part of the animal protein with soy protein (SP) in the diet contributed to more pronounced nephro- and cardioprotection in CKD, however, the data, available in the literature, are mainly represented by experimental studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research